Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here. The Food and Drug Administration (FDA) issued emergency authorization Saturday for a novel coronavirus ...

Before O’Malley, Reyna, and Hughes. Appeal from the District Court for the Northern District of California. Summary: Testing for the presence of a bacterium that causes tuberculosis and the primers ...

GENEVA and SUNNYVALE, Calif., July 16, 2020 /PRNewswire/ -- The Foundation for Innovative New Diagnostics (FIND) and Cepheid, Inc, announced today the launch of the new Xpert® MTB/XDR* test, which ...

UNION CITY, Calif. (AP) — Blood analysis systems developer Abaxis Inc. said Wednesday it will receive $17.25 million from medical test maker Cepheid Inc. as part of a patent litigation settlement.

) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Cepheid as such a stock due to the following factors: CPHD has an average dollar-volume (as ...

WASHINGTON, March 16 (Reuters) - The U.S. Food and Drug Administration said on Friday it had approved Cepheid Inc.'s rapid test for viral meningitis, a product that could help doctors more quickly ...

SAN FRANCISCO (MarketWatch) -- Cepheid Inc. on Thursday evening reported a second-quarter loss of $3.6 million, or 9 cents a share, compared with a loss of $3.7 million, or 9 cents a share, last year.

(Reuters) - Cepheid Inc said it signed deals with the Bill & Melinda Gates Foundation and three other aid organizations to make its tuberculosis diagnostic kit available at reduced prices in ...

Miller Andrew who is EVP, CFO at CEPHEID INC bought 860 shares at $17.11 per share for a total value of $8,041.70 on July 3, 2013. Following this transaction, the EVP, CFO owned 1,015 shares meaning ...

The U.S. FDA has granted an emergency use authorization (EUA) to Cepheid Inc., of Sunnyvale, Calif., for a rapid molecular diagnostic to detect SARS-CoV-2, the virus that causes COVID-19. The Xpert ...

The U.S. FDA has granted an emergency use authorization (EUA) to Cepheid Inc., of Sunnyvale, Calif., for a rapid molecular diagnostic to detect SARS-CoV-2, the virus that causes COVID-19. The Xpert ...